Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Lan Zhu-Sheng"'
Autor:
Ma Donghui, Baruch Dror, Shu Youmin, Yuan Kehu, Sun Zairen, Ma Kaiyan, Hoang Toan, Fu Wei, Min Li, Lan Zhu-Sheng, Wang Fangxun, Mull Lori, He Wei-Wu
Publikováno v:
BMC Biotechnology, Vol 12, Iss 1, p 88 (2012)
Abstract Background An antibody with cross-reactivity can create unexpected side effects or false diagnostic reports if used for clinical purposes. ERCC1 is being explored as a predictive diagnostic biomarker for cisplatin-based chemotherapy. High ER
Externí odkaz:
https://doaj.org/article/3d15858b6bc7446ca0436f03e8d30d17